Login
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc

idexx.com

IDEXX Laboratories (NASDAQ: IDXX) is a veterinary diagnostics company that develops and sells diagnostic products, services, and information management solutions primarily for companion animal veterinary practices. Revenue comes from selling analyzers and instruments placed in clinics, then generating recurring consumable and reagent sales alongside reference laboratory testing services and software subscriptions. The company operates through three reported segments: Companion Animal Group (CAG), which serves veterinarians with diagnostic and information management products; Livestock, Poultry and Dairy (LPD), which provides diagnostic products for livestock and poultry health and milk quality testing; and a third segment referenced in the filing. Customer commitment arrangements, where clinics sign multi-year contracts with minimum annual purchase obligations in exchange for incentives, create recurring revenue and switching costs. IDEXX competes with Ortho-Clinical Diagnostics (a QuidelOrtho subsidiary) in certain diagnostic categories. The company had a $1.25 billion unsecured credit facility as of the 10-K filed February 20, 2026, consisting of a $1 billion revolving facility and a $250 million term loan.

Products & Services

Companion Animal Group (CAG): in-clinic diagnostic analyzers, IDEXX VetLab Station (IVLS), reference laboratory testing services, information management solutions. Livestock, Poultry and Dairy (LPD): diagnostic products for livestock and poultry health, milk quality and safety testing products.

Revenue Model

Instrument placement followed by recurring consumable, reagent, and reference lab service revenue. Software and information management subscriptions through the CAG segment. Multi-year customer commitment arrangements provide minimum annual purchase guarantees in exchange for pricing incentives.

Customers & Markets

Primary customers are veterinary practices serving companion animals (pets). Secondary end markets include livestock producers, poultry operations, and dairy producers. Clinical visits driving pet-veterinarian interactions are a key demand driver for the CAG segment.

Geographic Exposure

International operations implied by reference to foreign currency exchange rate effects on organic revenue growth, but specific country or regional revenue breakdowns are not supported by the provided filing excerpts.

Financial Snapshot

Revenue
TTM
$4.446B
Gross Margin
TTM
62.04%
Net Income
TTM
$1.095B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
111.86%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.556B
Cash
2026 Q1
P/E
TTM
40.27
Free Cash Flow
TTM
$1.070B

Stock Price

Loading...
Market Cap: $44.101 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support